UNIGE document Scientific Article
previous document  unige:100672  next document
add to browser collection

Prévention de l’AVC chez les patients avec une fibrillation auriculaire

Sirimarco, Gaia
Hirt, Lorenz
Published in Revue médicale suisse. 2017, vol. 13, no. 560, p. 911-915
Abstract Oral anticoagulation with vitamin K antagonists (VKA) was the cornerstone of stroke prevention in atrial fibrillation (AF). This review article presents the state of the art, with regard to the treatment options developed over the past few years, the new oral anticoagulants (NOAC). A search in PubMed for relevant published studies has been performed. Dabigatran and apixaban were superior to warfarin to reduce stroke risk or systemic embolism ; dabigatran, rivaroxaban and edoxaban were non-inferior. All NOAC are globally non-inferior to warfarin for stroke prevention in non-valvular AF and they have a superior safety profile, with a reduced intracranial bleeding risk. They are now the first choice for treatment.
PMID: 28727359
Full text
Article (Published version) (431 Kb) - public document Free access
Research group Laboratoire de neuroimagerie clinique d'ultrasons ultrarapides (972)
(ISO format)
SIRIMARCO, Gaia et al. Prévention de l’AVC chez les patients avec une fibrillation auriculaire. In: Revue médicale suisse, 2017, vol. 13, n° 560, p. 911-915. https://archive-ouverte.unige.ch/unige:100672

406 hits



Deposited on : 2017-12-20

Export document
Format :
Citation style :